FAP: Not Just a Biomarker but Druggable Target in Liver Fibrosis

Cell Mol Gastroenterol Hepatol. 2023;15(4):1018-1019. doi: 10.1016/j.jcmgh.2022.12.018. Epub 2023 Jan 18.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Biomarkers
  • Humans
  • Liver Cirrhosis* / drug therapy
  • Serine Endopeptidases*

Substances

  • Serine Endopeptidases
  • Biomarkers